Raia Drogasil (RADL3) Investor presentation summary

Track record and market leadership

• Achieved 11x growth in store count and 9x increase in gross revenue since 2011 merger.

• Operates 3,453 pharmacies across all Brazilian states, ranking #1 in revenue and store count.

• Serves 51 million active customers with 429 million tickets in the last 12 months.

• Gross revenue reached R$45.5B in 3Q25 LTM, up 12% YoY; adjusted EBITDA at R$3.1B.

• Market share rose to 16.8% in 3Q25, with gains in every region.

Market dynamics and growth drivers

• Aging population drives demand, with those over 65 expected to reach 51 million by 2050.

• Pharmaceutical market CAGR of 13% from 2000 to 2024, reaching R$208B.

• Fragmented market offers consolidation opportunities; independents still hold 22.6% share.

• Average annual sales per pharmacy significantly higher than competitors.

Expansion and operational performance

• Guidance for 330-350 new pharmacies in 2026, with real IRR above 20%.

• 95% of Brazil’s A-class population within 1.5 km of a store.

• Consistent market share gains across all regions, especially Southeast and Northeast.